HETEROCYCLES, Vol. 67, No. 2, 2006
813
give 9 (45 mg, 71.4%) as a pale yellow crystalline powder; HPLC(50 mM KH2PO4-MeCN= 65:35) tR:
31.4(8), 30.3(9); mp 167.4oC (AcOH); IR(KBr): 1706.7, 1694.6, 1437.1, 1378.8 cm-1; 1H-NMR(300 MHz,
CDCl3): δ 3.19(s, 3H), 7.59-7.71(m, 2H), 7.79(d, J=8.2 Hz, 1H), 7.90(d, J=8.1 Hz, 1H), 8.09(d, J=8.2
Hz, 1H), 8.87(d, J=8.3 Hz, 0.8 Hz, 1H); 13C-NMR(75 MHz, CDCl3): δ 23.7, 118.3, 124.8, 127.4, 127.8,
128.6(2C), 129.3, 131.3, 134.7, 136.4, 168.9, 169.6; MS(ESI): m/z 212[M+H]+; Anal. Calcd for
C13H9NO2: C, 73.92; H, 4.29; N, 6.63. Found: C, 73.80; H, 4.19; N, 6.64.
8-Methoxy-2-methylbenzo[e]isoindole-1,3-dione (11). To a suspension of 8-methoxy-4,5-dihydro-
naphtho[1,2-c]furan-1,3-dione (10; 115 mg, 0.5 mmol) in AcOH (8.5 mL) were added 40% methylamine
(methanol solution) (0.08 mL, 1 mmol) and triethylamine (1.16 g, 11.5 mmol) at 0oC, and the resulting
mixture was stirred at 120oC for 24 h. After cooling, the resulting precipitates were collected by filtration,
washed with MeOH (2 mL x 3) and dried in vacuo to give 11 (59 mg, 48.8%) as a pale yellow crystalline
powder; HPLC(50 mM KH2PO4-MeCN= 30:70) tR: 3.7(10), 4.3(11); mp 173.8 oC (AcOH); IR(KBr):
1753.3, 1708.5, 1695.9, 1377.8 cm-1; 1H-NMR(300 MHz, CDCl3): δ 3.19(s, 3H), 3.99(s, 3H), 7.23(dd,
J=9.1 Hz, 2.6 Hz, 1H), 7.64(d, J=8.1 Hz, 1H), 7.76(d, J=9.1 Hz, 1H), 7.98(d, J=8.1 Hz, 1H), 8.14(d,
J=2.4 Hz, 1H); 13C-NMR(75 MHz, CDCl3): δ 23.6, 55.6, 102.0, 116.1, 122.1, 125.5, 129.6, 130.0,
131.7, 132.3, 134.3, 160.5, 169.1, 170.0; MS(ESI): m/z 242[M+H]+; Anal. Calcd for C14H11NO3.0.1H2O:
C, 68.73; H, 4.61; N, 5.73. Found: C, 68.74; H, 4.50; N, 5.77.
2-Benzyl-7-bromobenzo[e]isoindole-1,3-dione (12). To a suspension of 4 (84 mg, 0.3 mmol) in AcOH
(5.1 mL) were added benzylamine (64 mg, 0.6 mmol) and triethylamine (698 mg, 6.9 mmol) at 0oC, and
the resulting mixture was stirred at 120oC for 24 h. After cooling, the resulting precipitates were collected
by filtration, washed with MeOH (1.5 mL x 3) and dried in vacuo to give 12 (61 mg, 55.5%) as an orange
crystalline powder; HPLC(50 mM KH2PO4-MeCN= 30:70) tR: 4.8(4), 13.0(12); mp 157.9 oC (AcOH);
IR(KBr): 1697.7, 1397.3, 1387.9, 1352.8 cm-1; 1H-NMR(300 MHz, CDCl3): δ 4.88(s, 2H),
7.24-7.35(m, 3H), 7.45-7.48(m, 2H), 7.75(dd, J=9.0 Hz, 1.9 Hz, 1H), 7.85(d, J=8.3 Hz, 1H), 8.01(d,
J=8.3 Hz, 1H), 8.08(d, J=1.7 Hz, 1H), 8.77(d, J=9.0 Hz, 1H); 13C-NMR(75 MHz, CDCl3): δ 41.6,
119.7, 123.5, 126.3, 126.5, 127.7, 127.8, 128.6(2C), 128.7(2C), 130.7, 131.4, 132.9, 133.8, 136.4, 137.5,
168.2, 168.8; MS(ESI): m/z 366[M+H]+; Anal. Calcd for C19H12NO2Br: C, 62.32; H, 3.30; N, 3.82.
Found: C, 62.24; H, 3.36; N, 3.96.
7-Bromo-2-phenylbenzo[e]isoindole-1,3-dione (13). To a suspension of 4 (84 mg, 0.3 mmol) in AcOH
(5.1 mL) were added phenylamine (56 mg, 0.6 mmol) and triethylamine (698 mg, 6.9 mmol) at 0oC, and
the resulting mixture was stirred at 120oC for 24 h. After cooling, the resulting precipitates were collected
by filtration, washed with MeOH (1.5 mL x 3) and dried in vacuo to give 13 (92 mg, 86.8%) as a yellow
crystalline powder; HPLC(50 mM KH2PO4-MeCN= 30:70) tR: 4.8(4), 9.2(13); mp 292.2 oC (AcOH);